| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.094 | 0.7 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.025 | 0.8 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.018 | 0.8 |